OTC intron 4 variations mediate pathogenic splicing patterns caused by the c.386G>A mutation in humans and spfash mice, and govern susceptibility to RNA-based therapies.
Molecular Medicine (Cambridge, Mass.)
Sacchetto, Claudia C; Peretto, Laura L; Baralle, Francisco F; Maestri, Iva I; Tassi, Francesca F; Bernardi, Francesco F; van de Graaf, Stan F J SFJ; Pagani, Franco F; Pinotti, Mirko M; Balestra, Dario D
OTC intron 4 variations mediate pathogenic splicing patterns caused by the c.386G>A mutation in humans and spfash mice, and govern susceptibility to RNA-based therapies.
Molecular Medicine (Cambridge, Mass.)
Sacchetto, Claudia C; Peretto, Laura L; Baralle, Francisco F; Maestri, Iva I; Tassi, Francesca F; Bernardi, Francesco F; van de Graaf, Stan F J SFJ; Pagani, Franco F; Pinotti, Mirko M; Balestra, Dario D
Integrated molecular drivers coordinate biological and clinical states in melanoma.
Nature Genetics
Conway, Jake R JR; Dietlein, Felix F; Taylor-Weiner, Amaro A; AlDubayan, Saud S; Vokes, Natalie N; Keenan, Tanya T; Reardon, Brendan B; He, Meng Xiao MX; Margolis, Claire A CA; Weirather, Jason L JL; Haq, Rizwan R; Schilling, Bastian B; Stephen Hodi, F F; Schadendorf, Dirk D; Liu, David D; Van Allen, Eliezer M EM
NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics.
Molecular Oncology
Cirenajwis, Helena H; Lauss, Martin M; Ekedahl, Henrik H; Törngren, Therese T; Kvist, Anders A; Saal, Lao H LH; Olsson, Håkan H; Staaf, Johan J; Carneiro, Ana A; Ingvar, Christian C; Harbst, Katja K; Hayward, Nicholas K NK; Jönsson, Göran G